help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, Y.
Right arrow Articles by Simpson, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, Y.
Right arrow Articles by Simpson, E. R.

Molecular Endocrinology, Vol 10, 1350-1357, Copyright © 1996 by Endocrine Society


ARTICLES

Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4

Y Zhao, JE Nichols, R Valdez, CR Mendelson and ER Simpson
Department of Obstetrics/Gynecology, University of Texas Southwestern Medical Center, Dallas 75235, USA.

Expression of aromatase P450 (P450arom; the product of the CYP19 gene) in human adipose stromal cells in primary culture is markedly stimulated by serum in the presence of dexamethasone (DEX). Under these conditions, the majority of P450arom transcripts contain untranslated exon 1.4 at their 5'-ends. Previously, we observed that the region of the CYP19 gene upstream of exon 1.4 contains a TATA-less promoter, a glucocorticoid response element, and an interferon-gamma-activating sequence. These act to mediate the action of interleukin-6 and related cytokines to stimulate aromatase expression in the presence of DEX. In the present study, we found that tumor necrosis factor-alpha (TNF alpha) also acts synergistically with DEX to stimulate aromatase expression in adipose stromal cells in serum-free medium. We observed that the action of TNF alpha can be mimicked by ceramide. Maximal aromatase activity was obtained when cells were incubated with 5 ng/ml TNF alpha or 100 nM ceramide in the presence of 250 nM DEX. Levels of c- fos and c-jun proteins also were increased by TNF alpha or ceramide in the presence of DEX. Upstream of the interferon-gamma-activating sequence site there is an imperfect activating protein-1 (AP-1) binding site (2-bp mismatch). Gel retardation analysis using nucleotide probes containing the putative AP-1-binding sequence and nuclear extracts of human adipose stromal cells cultured in the presence of TNF alpha or ceramide plus DEX revealed that adipose stromal cells nuclear proteins bind to this site and that binding was competed by a 100-fold excess of a consensus AP-1 sequence. In addition, binding activity was competed by both anti-c-fos and anti-c-jun sera. Mutation or deletion of the putative AP-1 element resulted in the loss of TNF alpha- plus DEX- induced activity of reporter constructs comprised of 515 bp of the exon 1.4 flanking sequence linked to the luciferase gene. These results suggest that TNF alpha, probably acting through ceramide formation, stimulates the binding of both c-fos and c-jun to the AP-1 element upstream of exon 1.4. These act cooperatively with the ligand-activated glucocorticoid receptor to induce aromatase expression in adipose stromal cells in primary culture. We conclude that this TNF alpha signal transduction pathway may play an important role in the regulation of estrogen biosynthesis in adipose tissue.


This article has been cited by other articles:


Home page
ChestHome page
C. Adrie, E. Azoulay, A. Francais, C. Clec'h, L. Darques, C. Schwebel, D. Nakache, S. Jamali, D. Goldgran-Toledano, M. Garrouste-Orgeas, et al.
Influence of Gender on the Outcome of Severe Sepsis: A Reappraisal
Chest, December 1, 2007; 132(6): 1786 - 1793.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Ramirez-Lorca, A. Grilo, M. T. Martinez-Larrad, L. Manzano, F. J. Serrano-Hernando, F. J. Moron, V. Perez-Gonzalez, J. L. Gonzalez-Sanchez, J. Fresneda, R. Fernandez-Parrilla, et al.
Sex and Body Mass Index Specific Regulation of Blood Pressure by CYP19A1 Gene Variants
Hypertension, November 1, 2007; 50(5): 884 - 890.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Chen, S. Reierstad, Z. Lin, M. Lu, C. Brooks, N. Li, J. Innes, and S. E. Bulun
Prostaglandin E2 Induces Breast Cancer Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose Fibroblasts
Cancer Res., September 15, 2007; 67(18): 8914 - 8922.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
L. Vona-Davis and D. P Rose
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
Endocr. Relat. Cancer, June 1, 2007; 14(2): 189 - 206.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
G. G. Gosman, H. I. Katcher, and R. S. Legro
Obesity and the role of gut and adipose hormones in female reproduction
Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. H. Straub, P. Harle, M. Kriegel, J. Scholmerich, and H.-M. Lorenz
Adrenal and Gonadal Hormone Variations during a Febrile Attack in a Woman with Tumor Necrosis Factor Receptor-Associated Periodic Syndrome
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5884 - 5887.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. E. Bulun, Z. Lin, G. Imir, S. Amin, M. Demura, B. Yilmaz, R. Martin, H. Utsunomiya, S. Thung, B. Gurates, et al.
Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment
Pharmacol. Rev., September 1, 2005; 57(3): 359 - 383.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. S. Diaz-Cruz, C. L. Shapiro, and R. W. Brueggemeier
Cyclooxygenase Inhibitors Suppress Aromatase Expression and Activity in Breast Cancer Cells
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2563 - 2570.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Miyoshi, S. J. Kim, K. Akazawa, S. Kamigaki, S. Ueda, T. Yanagisawa, T. Inoue, T. Taguchi, Y. Tamaki, and S. Noguchi
Down-Regulation of Intratumoral Aromatase Messenger RNA Levels by Docetaxel in Human Breast Cancers
Clin. Cancer Res., December 15, 2004; 10(24): 8163 - 8169.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Kovacic, C. J. Speed, E. R. Simpson, and C. D. Clyne
Inhibition of Aromatase Transcription Via Promoter II by Short Heterodimer Partner in Human Preadipocytes
Mol. Endocrinol., January 1, 2004; 18(1): 252 - 259.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Bourguiba, S. Chater, C. Delalande, M. Benahmed, and S. Carreau
Regulation of Aromatase Gene Expression in Purified Germ Cells of Adult Male Rats: Effects of Transforming Growth Factor {beta}, Tumor Necrosis Factor {alpha}, and Cyclic Adenosine 3',5'-Monosphosphate
Biol Reprod, August 1, 2003; 69(2): 592 - 601.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. A. Feltus, W. J. Kovacs, W. Nicholson, C. M. Silva, S. K. Nagdas, N. A. Ducharme, and M. H. Melner
Epidermal Growth Factor Increases Cortisol Production and Type II 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4-Isomerase Expression in Human Adrenocortical Carcinoma Cells: Evidence for a Stat5-Dependent Mechanism
Endocrinology, May 1, 2003; 144(5): 1847 - 1853.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H.-J. Yang, M. Shozu, K. Murakami, H. Sumitani, T. Segawa, T. Kasai, and M. Inoue
Spatially Heterogenous Expression of Aromatase P450 through Promoter II Is Closely Correlated with the Level of Steroidogenic Factor-1 Transcript in Endometrioma Tissues
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3745 - 3753.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. L. Rubin, J. H. Duong, C. D. Clyne, C. J. Speed, Y. Murata, C. Gong, and E. R. Simpson
Ligands for the Peroxisomal Proliferator-Activated Receptor {gamma} and the Retinoid X Receptor Inhibit Aromatase Cytochrome P450 (CYP19) Expression Mediated by Promoter II in Human Breast Adipose
Endocrinology, August 1, 2002; 143(8): 2863 - 2871.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. HERRMANN, J. SCHOLMERICH, and R. H. STRAUB
Influence of Cytokines and Growth Factors on Distinct Steroidogenic Enzymes in Vitro: A Short Tabular Data Collection
Ann. N.Y. Acad. Sci., June 1, 2002; 966(1): 166 - 186.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. D. Clyne, C. J. Speed, J. Zhou, and E. R. Simpson
Liver Receptor Homologue-1 (LRH-1) Regulates Expression of Aromatase in Preadipocytes
J. Biol. Chem., May 31, 2002; 277(23): 20591 - 20597.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. R. Simpson and S. R. Davis
Minireview: Aromatase and the Regulation of Estrogen Biosynthesis--Some New Perspectives
Endocrinology, November 1, 2001; 142(11): 4589 - 4594.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zhou, B. Gurates, S. Yang, S. Sebastian, and S. E. Bulun
Malignant Breast Epithelial Cells Stimulate Aromatase Expression via Promoter II in Human Adipose Fibroblasts: An Epithelial-Stromal Interaction in Breast Tumors Mediated by CCAAT/Enhancer Binding Protein {beta}
Cancer Res., March 1, 2001; 61(5): 2328 - 2334.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Yasui, J. D. Potter, J. L. Stanford, M. A. Rossing, M. D. Winget, M. Bronner, and J. Daling
Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection
Cancer Epidemiol. Biomarkers Prev., January 1, 2001; 10(1): 9 - 16.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
G. L. Rubin, Y. Zhao, A. M. Kalus, and E. R. Simpson
Peroxisome Proliferator-activated Receptor {{gamma}} Ligands Inhibit Estrogen Biosynthesis in Human Breast Adipose Tissue: Possible Implications for Breast Cancer Therapy
Cancer Res., March 1, 2000; 60(6): 1604 - 1608.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Shozu, Y. Zhao, S. E. Bulun, and E. R. Simpson
Multiple Splicing Events Involved in Regulation of Human Aromatase Expression by a Novel Promoter, I.6
Endocrinology, April 1, 1998; 139(4): 1610 - 1617.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society